Cytek Biosciences is setting the new standard for full spectrum flow cytometry with the new Cytek Aurora Evo Flow Cytometer

In a move that underscores its dedication to shaping the future of cell analysis, Cytek Biosciences, Inc. has announced the launch of the Cytek Aurora^™ Evo system, a new full spectrum flow cytometer that improves on its flagship Cytek Aurora system.

First launched in 2017 to address the limitations of existing flow cytometry technologies, Cytek’s Full Spectrum Profiling^™ (FSP^®) systems have become the spectral technology of choice for researchers worldwide, with over 2,600 peer-reviewed publications citing its use – more than any other spectral flow cytometer.

Building on this groundbreaking success, the new Cytek Aurora Evo system has been reengineered to carry forward the proven reliability and reproducibility of the Cytek Aurora system, while introducing high-throughput and automation capabilities to meet the demands of modern research. The Cytek Aurora Evo system utilizes Cytek’s FSP technology, continuing to provide the field-tested capability to run large multicolor experiments without compromising data quality, as well as an unparalleled level of assay flexibility. The ability to resolve both small particles and large cells on a single instrument allows scientists to tackle a wider range of applications with confidence. The newly added capabilities of improved sample throughput, automated instrument maintenance, and data harmonization were all added to empower researchers to accelerate discoveries with greater speed and confidence.

With increasing demand for high-performance, flexible, and efficient cell analysis tools, the new Cytek Aurora Evo flow cytometer is well-positioned to meet the evolving needs of researchers and further drive the adoption of spectral flow cytometry. Key features and benefits of the new system include:

• Instrument Standardization: Harmonized instruments allow for consistent, accurate and reproducible biological data across systems, labs and time.
• High-Resolution and Throughput: A unique optical and electronics design enables excellent sensitivity and resolution across flow rates, from low (15 µL/min) to max (200 µL/min). Samples can now be acquired 2x faster than before.
• Small Particle Detection: Previously available as an optional upgrade on the Cytek Aurora system, this capability is now built into the new Cytek Aurora Evo flow cytometer, enabling researchers to detect and resolve extracellular vesicles, viruses, bacteria and other nanoparticles.
• Automation Capabilities: Minimize instrument maintenance and maximize efficiency. An integrated plate loader supports multiple carrier types, offering flexible user modes for both low carryover and high-throughput needs. Automated startup and shutdown further streamline workflows, reducing downtime while ensuring high-quality, high-resolution data.

Recognized as a pioneer in spectral flow cytometry, Cytek’s distinctive approach is renowned for its profound influence on advancing the understanding of cell biology, immunology, oncology and targeted therapeutic methodologies.

“Cytek’s Aurora and Northern Lights^™ systems have helped revolutionize immunology research and single-cell analysis,” said Ming Yan, Ph.D., CTO of Cytek Biosciences. “Over the years, we have continuously pushed the boundaries of what’s possible in spectral flow cytometry. With this latest launch of the Cytek Aurora Evo system, we’ve integrated these advancements into a powerful, high-throughput workhorse that delivers an unmatched combination of performance, reliability, efficiency and ease of use – enabling more scientists to leverage the full potential of spectral flow cytometry.”

The Cytek Aurora Evo system will make its public debut at CYTO 2025, with demonstrations taking place in Cytek’s booth.

Want the latest science news straight to your inbox? Become a SelectScience member for free today>>